Abstract
Background: Although quality improvement interventions for acute heart failure have been studied in high-income countries, none have been studied in low- or middle-income country settings where quality of care can be lower. We evaluated the effect of a quality improvement toolkit on process of care measures and clinical outcomes in patients hospitalized for acute heart failure in 8 hospitals in Kerala, India utilizing an interrupted time series design from February 2018 to August 2018. Methods: The quality improvement toolkit included checklists, audit-and-feedback reports, and patient education materials. The primary outcome was rate of discharge guideline-directed medical therapy for patients with heart failure with reduced ejection fraction. We used mixed effect logistic regression and interrupted time series models for analysis. Results: Among 1400 participants, mean (SD) age was 66.6 (12.2) years, and 38% were female. Mean (SD) left ventricular ejection fraction was 35.2% (9.7%). The primary outcome was observed in 41.3% of participants in the intervention period and 28.1% of participants in the control period (difference 13.2%; 95% CI 6.8, 19.0; adjusted OR = 1.70; 95% CI 1.17, 2.48). Interrupted time series model demonstrated highest rate of guideline-directed medical therapy at discharge in the initial weeks following intervention delivery with a concomitant decline over time. Improvements were observed in discharge process of care measures, including diet counseling, weight monitoring instructions, and scheduling of outpatient clinic follow-up but not hospital length of stay nor inpatient mortality. Conclusions: Higher rates of guideline-directed medical therapy at discharge were observed in Kerala. Broader implementation of this quality improvement intervention may improve heart failure care in low- and middle-income countries.
Original language | English (US) |
---|---|
Pages (from-to) | 123-129 |
Number of pages | 7 |
Journal | International Journal of Cardiology |
Volume | 329 |
DOIs | |
State | Published - Apr 15 2021 |
Funding
AA received funding from the Fogarty International Center of the National Institutes of Health, Duke Global Health Institute and Duke Hubert-Yeargan Center for Global Health for this research. Research reported in this publication was supported by the Fogarty International Center and National Institute of Mental Health , of the National Institutes of Health under Award Number D43TW010543 . The other funders listed (Boeringher Ingelheim, Novartis, BUPA, AstraZeneca, American Heart Association, Verily, American Medical Association) did not fund the research reported in this publication. They are part of the disclosures of one of the co-authors. AA received funding from the Fogarty International Center of the National Institutes of Health, Duke Global Health Institute and Duke Hubert-Yeargan Center for Global Health for this research. Research reported in this publication was supported by the Fogarty International Center and National Institute of Mental Health, of the National Institutes of Health under Award Number D43TW010543. The other funders listed (Boeringher Ingelheim, Novartis, BUPA, AstraZeneca, American Heart Association, Verily, American Medical Association) did not fund the research reported in this publication. They are part of the disclosures of one of the co-authors.MDH received funding from the World Heart Federation to serve as its senior program advisor for the Emerging Leaders program, which is supported by Boehringer Ingelheim and Novartis with previous support from BUPA and AstraZeneca. MDH also receives support from the American Heart Association, Verily, and AstraZeneca and American Medical Association for work unrelated to this research.
Keywords
- Heart failure
- India
- Quality improvement
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine